<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0185476</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-20937</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Nephrology</subject><subj-group><subject>Chronic kidney disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal system</subject><subj-group><subject>Kidneys</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal system</subject><subj-group><subject>Kidneys</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Regression analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Regression analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Behavior</subject><subj-group><subject>Habits</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Coronary heart disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Coronary heart disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Blood pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Blood pressure</subject><subj-group><subject>Hypertension</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Regression analysis</subject><subj-group><subject>Linear regression analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Regression analysis</subject><subj-group><subject>Linear regression analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers</article-title>
<alt-title alt-title-type="running-head">Kidney function and genetic polymorphisms of atherosclerotic diseases and chronic kidney diseases</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Kubo</surname>
<given-names>Yoko</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Imaizumi</surname>
<given-names>Takahiro</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2891-5424</contrib-id>
<name name-style="western">
<surname>Ando</surname>
<given-names>Masahiko</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Nakatochi</surname>
<given-names>Masahiro</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Yasuda</surname>
<given-names>Yoshinari</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Honda</surname>
<given-names>Hiroyuki</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kuwatsuka</surname>
<given-names>Yachiyo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kato</surname>
<given-names>Sawako</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kikuchi</surname>
<given-names>Kyoko</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kondo</surname>
<given-names>Takaaki</given-names>
</name>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Iwata</surname>
<given-names>Masamitsu</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Nakashima</surname>
<given-names>Toru</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Yasui</surname>
<given-names>Hiroshi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Takamatsu</surname>
<given-names>Hideki</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Okajima</surname>
<given-names>Hiroshi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Yoshida</surname>
<given-names>Yasuko</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Maruyama</surname>
<given-names>Shoichi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of CKD Initiatives, Nagoya University Graduate School of Medicine, Nagoya, Japan</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Biotechnology, Graduate School of Engineering, Nagoya University, Nagoya, Japan</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Program in Radiological and Medical Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Safety and Health Promotion Division, Toyota Motor Corporation, Toyota, Japan</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>R &amp; D Management Division, Toyota Motor Corporation, Toyota, Japan</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Innovative Research Center for Preventative Medical Engineering, Nagoya University, Nagoya, Japan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Shimosawa</surname>
<given-names>Tatsuo</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>The University of Tokyo, JAPAN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The company provided support in the form of salaries for the five authors (Masamitsu Iwata, Toru Nakashima, Hiroshi Yasui, Hideki Takamatsu, and Hiroshi Okajima), and it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also declare that this commercial affiliation does not alter our adherence to all PLOS ONE policies on sharing data and materials.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">mando@med.nagoya-u.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>10</issue>
<elocation-id>e0185476</elocation-id>
<history>
<date date-type="received">
<day>1</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Kubo et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0185476"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Several single nucleotide polymorphisms (SNPs) have been implicated in the predisposition to chronic kidney disease (CKD). Atherosclerotic disease is deeply involved in the incidence of CKD; however, whether SNPs related to arteriosclerosis are involved in CKD remains unclear. This study aimed to identify SNPs associated with CKD and to examine whether risk allele accumulation is associated with CKD.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>We conducted a cross-sectional study using data of 4814 male workers to examine the association between estimated glomerular filtration rate (eGFR) and 59 candidate polymorphisms (17 CKD, 42 atherosclerotic diseases). We defined the genetic risk score (GRS) as the total number of risk alleles that showed a significant association in this analysis and examined the relationship with CKD (eGFR &lt; 60 ml/min/1.73m<sup>2</sup>). Multivariate logistic regression, discrimination by area under the receiver operating characteristic curve, integrated discrimination improvement (IDI), and category-free net reclassification improvement (cNRI) were evaluated.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>In total, 432 participants were categorized as having CKD. We found eight candidate SNPs with <italic>P</italic> value &lt; 0.05 (<italic>CX3CR1</italic> rs3732379, <italic>SHROOM3</italic> rs17319721, <italic>MTP</italic> rs1800591, <italic>PIP5K1B</italic> rs4744712, <italic>APOA5</italic> rs662799, <italic>BRAP</italic> rs3782886, <italic>SPATA5L1</italic> rs2467853, and <italic>MCP1</italic> rs1024611) in the multivariate linear regression adjusted for age, body mass index, systolic blood pressure, and fasting blood glucose. Among these eight SNPs, <italic>BRAP</italic> rs3782886 and <italic>SPATA5L1</italic> rs2467853 were significantly associated with eGFR (false discovery rate &lt; 0.05). GRS was significantly associated with CKD (odds ratio, 1.17; 95% confidence interval, 1.09–1.26). C-statisics improved from 0.775 to 0.780 but showed no statistical significance. However, adding GRS significantly improved IDI and cNRI (0.0057, P = 0.0028, and 0.212, P &lt; 0.001, respectively).</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>After adjustment for clinical factors, kidney function was associated with <italic>BRAP</italic> rs3782886 and <italic>SPATA5L1</italic> rs2467853 and the GRS for CKD that we developed was associated CKD.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>Support for this work was provided by the Center of Innovation Stream Program at the Nagoya University Institute of Innovation for Future Society, government-led Comprehensive Special Zones for Local Revitalization project, and Toyota Motor Corporation Limited. Five authors (Masamitsu Iwata, Toru Nakashima, Hiroshi Yasui, Hideki Takamatsu, and Hiroshi Okajima) have an affiliation to the commercial funders of this research study: Toyota Motor Corporation Limited. We carefully reviewed the contribution of these authors and confirmed that although the funder provided support in the form of salaries for the five authors, it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="3"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Chronic kidney disease (CKD) is an independent risk factor for end-stage renal disease (ESRD), cardiovascular disease (CVD), and all-cause mortality in the general population [<xref ref-type="bibr" rid="pone.0185476.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0185476.ref004">4</xref>]. The number of patients with CKD is approximately 13.3 million, representing about 13% of the Japanese adult population [<xref ref-type="bibr" rid="pone.0185476.ref005">5</xref>]. The incidence of CKD stage III or higher increases with age [<xref ref-type="bibr" rid="pone.0185476.ref006">6</xref>]. Moreover, lifestyle-related chronic diseases mainly develop in middle age; thus, predicting the risk of kidney disease in this age group is vital to help prevent the progress towards ESRD and CVD.</p>
<p>Several population-based cohort studies have identified clinical factors associated with CKD, including age, hypertension, diabetes mellitus, and smoking [<xref ref-type="bibr" rid="pone.0185476.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0185476.ref007">7</xref>]. These are also common risk factors for developing atherosclerotic diseases [<xref ref-type="bibr" rid="pone.0185476.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0185476.ref011">11</xref>]. While there are numerous clinical risk factors for CKD, genetic factors also contribute to the development of CKD. Based on genome-wide association studies (GWAS) and candidate gene studies, various single nucleotide polymorphisms (SNPs) have been associated with CKD [<xref ref-type="bibr" rid="pone.0185476.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0185476.ref017">17</xref>]. CKD and atherosclerotic diseases have common risk factors; hence, the genetic background may also be common.</p>
<p>We have reported a number of studies that examined several SNPs associated with chronic lifestyle diseases, such as hypertension, obesity, and metabolic syndrome, among medical checkup examinees [<xref ref-type="bibr" rid="pone.0185476.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0185476.ref020">20</xref>]. We developed an SNPs measuring system to evaluate the risk for chronic lifestyle diseases, which includes SNPs related to CKD and atherosclerotic diseases, such as hypertension, stroke, coronary artery disease, and carotid artery disease. In this study, we used the same SNPs and examined their association with kidney function.</p>
<p>This study aimed to evaluate the role of SNPs related to CKD and atherosclerotic diseases in estimated glomerular filtration rate (eGFR) among Japanese male workers and to determine whether the total number of risk alleles is associated with CKD. The results can be useful to predict CKD risk among middle-aged men with or without atherosclerotic risk factors based on the number of genetic risk alleles.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec007">
<title>Study participants</title>
<p>All male employees of Toyota Motor Co., Ltd. in Japan and those who participated in the annual health examination in 2010 were enrolled in this study. Only those who consented to DNA sampling were included, and the DNA samples were obtained between 2011 and 2014 from 5112 individuals. In this analysis, we excluded those whose creatinine level data were missing. Consequently, the final number of study participants was 4814. The study protocol was approved by the ethics committee of Nagoya University School of Medicine (No. 1089–4), and the study was conducted in accordance with the guidelines of the Declaration of Helsinki. All the participants provided written informed consent. This trial was registered at umin.ac.jp as UMIN000016266.</p>
</sec>
<sec id="sec008">
<title>Lifestyle evaluation</title>
<p>The lifestyle of participants was evaluated using self-administered questionnaires, which included items on smoking, stress, exercise habits, and drinking habits. Smoking was defined as the current smoking status of the participants and stress as self-reported psychological stress. Responses for drinking habits were divided into four categories: none, &lt;2 days/week, 3–6 days/ week, and every day. Exercise habits were also divided into three categories: none, &lt;6 days/week, and every day.</p>
</sec>
<sec id="sec009">
<title>Clinical parameters and outcome definition</title>
<p>The health examinations included physical measurements and serum biochemical measurements. Body mass index (BMI) was calculated as follows: weight (kg)/height (m<sup>2</sup>), while blood pressure (BP) was measured in the sitting position using an automatic sphygmomanometer (Kentaro HBP-9020; Omron, Tokyo, Japan).</p>
<p>The biochemical measurements included total cholesterol, triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), fasting blood glucose (FBG), HbA1c, uric acid (UA), and creatinine levels. The following equation was employed to calculate eGFR, as described by Matsuo et al. [<xref ref-type="bibr" rid="pone.0185476.ref021">21</xref>]:
<disp-formula id="pone.0185476.e001">
<alternatives>
<graphic id="pone.0185476.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0185476.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mrow><mml:mtext>Estimated</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>GFR</mml:mtext><mml:mspace width="4.pt"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>eGFR</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>194</mml:mn><mml:mspace width="4.pt"/><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mspace width="4.pt"/><mml:mtext>standardized</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>serum</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>creatinine</mml:mtext></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1.094</mml:mn></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mspace width="4.pt"/><mml:mtext>age</mml:mtext></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.287</mml:mn></mml:mrow></mml:msup></mml:mrow>
</mml:math>
</alternatives>
</disp-formula></p>
<p>Moreover, the positive result in the urine dipstick test represents urinary protein. CKD was defined as eGFR &lt; 60 ml/min/m<sup>2</sup>.</p>
</sec>
<sec id="sec010">
<title>SNP selection</title>
<p>In our previous study, we developed an SNP measuring system including 99 candidate SNPs that were associated with coronary heart disease, hypertension, dyslipidemia, diabetes mellitus, hyperuricemia, renal disease, or obesity [<xref ref-type="bibr" rid="pone.0185476.ref018">18</xref>]. Here, we selected 59 candidate SNPs that were associated with CKD and diseases related to atherosclerosis, including hypertension, coronary artery disease, stroke, and carotid artery disease. Detailed information of SNPs is shown in <xref ref-type="supplementary-material" rid="pone.0185476.s001">S1 Table</xref>.</p>
</sec>
<sec id="sec011">
<title>Genotyping the SNPs</title>
<p>DNA was anonymously extracted from blood samples of the participants (0.2 mL each) at DNA Chip Research Inc. (QIAamp<sup>®</sup> series; QIAGEN K.K., Tokyo, Japan). All SNPs were genotyped using the DigiTag2 assay [<xref ref-type="bibr" rid="pone.0185476.ref022">22</xref>].</p>
<p>Primers, probe sequences, and polymerase chain reaction conditions for the SNPs in the original cohort were similar to those described previously [<xref ref-type="bibr" rid="pone.0185476.ref018">18</xref>]. All the laboratory technicians were blinded to the participants’ identity, demographic characteristics, and study outcomes. Our study’s laboratory protocol was registered at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.17504/protocols.io.jmick4e" xlink:type="simple">http://dx.doi.org/10.17504/protocols.io.jmick4e</ext-link></p>
</sec>
<sec id="sec012">
<title>Statistical analysis</title>
<p>The clinical characteristics of the participants are presented as numbers and percentages for qualitative variables (i.e., smoking, exercise habits, and drinking habits), and as means and standard deviations or medians and interquartile ranges (IQRs) for quantitative variables (i.e., age, BMI, abdominal circumference, systolic blood pressure (SBP), and diastolic blood pressure (DBP)) as appropriate.</p>
<p>For each SNP, a score of 0, 1, or 2 was assigned depending on the number of minor alleles. For example, if A is the minor allele, the genotype aa corresponds to zero minor alleles, Aa corresponds to the presence of one minor allele, and AA corresponds to the presence of two minor alleles. The SNP score was treated as a continuous variable.</p>
<p>Initially, we examined the association between eGFR and SNPs using linear regression, assuming an additive genetic model adjusted for age, BMI, SBP, and FBG. Considering the multiple comparisons of genotypes with eGFR, the false discovery rate (FDR) was calculated from the distribution of <italic>P</italic> values for regression analysis of the 59 polymorphisms. We considered polymorphisms with an FDR of &lt; 0.05 to be strongly associated with eGFR, while polymorphisms with a <italic>P</italic> value &lt; 0.05 were considered to be potentially associated with kidney function. The genetic risk score (GRS) was calculated as the sum of the total number of risk alleles. In addition, we also constructed a weighted model to reflect the difference in the effect of each risk variant. To estimate the effect size of each risk variant, we performed logistic regression analysis in which the dependent variable was the presence of CKD and the independent variables were eight SNPs. The weighted genetic risk score (wGRS) was appropriately calculated based on the estimated weights in the logistic regression analysis. Moreover, based on the logistic regression analysis, we appropriately assigned integer coefficients to each variant to construct the wGRS.</p>
<p>Subsequently, we evaluated the association between CKD and GRS. Multivariate logistic regression analysis adjusted for the factors that we obtained from health examination data and is associated adjusted for the factors obtained from the health examination data revealed an association with CKD. In the multivariable logistic regression analysis, we set three adjusting models as follows:</p>
<list list-type="simple">
<list-item><p>Model 1: adjusted for age, BMI, SBP, and FBG</p></list-item>
<list-item><p>Model 2: model 1 + exercise habit, drinking habit, smoking, and stress</p></list-item>
<list-item><p>Model 3: model 2 + LDL cholesterol, uric acid, and urinary protein through positive urine dipstick test</p></list-item>
</list>
<p>Model 1 contains major metabolic components and has a set of variables common in the multiple regression analysis of eGFR. Model 2 contains lifestyle information, which we selected based on literature review [<xref ref-type="bibr" rid="pone.0185476.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0185476.ref024">24</xref>]. Model 3 contains other blood chemical tests, including urine dipstick test. Constructing multiple models enables the evaluation of whether lifestyle and other factors (e.g., proteinuria or serum uric acid) could affect GRS.</p>
<p>We also evaluated c-statistics, integrated discrimination improvement (IDI), and net reclassification improvement (NRI) to determine how the GRS improved outcome prediction [<xref ref-type="bibr" rid="pone.0185476.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0185476.ref026">26</xref>]. IDI and NRI were assessed as category-free and thus could represent the average improvement in sensitivity across all possible cutoffs. <italic>P</italic> &lt; 0.05 was considered statistically significant. The data were analyzed using Stata MP 14.2 (StataCorp LLC, Texas, USA).</p>
</sec>
</sec>
<sec id="sec013" sec-type="results">
<title>Results</title>
<sec id="sec014">
<title>Clinical characteristics</title>
<p>Clinical characteristics (clinical parameters, lifestyle data, and meal purchase data) of the study participants are shown in <xref ref-type="table" rid="pone.0185476.t001">Table 1</xref>. The number of the participants with CKD was 432 (9.85%). Participants with CKD were older and had higher BMI, SBP and DBP, BUN, UA, TG, LDL cholesterol, and FBG. The proportion of current smokers and daily drinkers was higher in the control group.</p>
<table-wrap id="pone.0185476.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0185476.t001</object-id>
<label>Table 1</label> <caption><title>Clinical characteristics between the participants with or without chronic kidney disease.</title></caption>
<alternatives>
<graphic id="pone.0185476.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify">Characteristics</th>
<th align="center">Number of data</th>
<th align="center">Total</th>
<th align="center">CKD<break/>(N = 432)</th>
<th align="center">Control<break/>(N = 4382)</th>
<th align="center"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Age</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">47.3±6.25</td>
<td align="center" style="background-color:#F2F2F2">50.2±4.76</td>
<td align="center" style="background-color:#F2F2F2">47.0±6.30</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>Body mass index</bold></td>
<td align="center">4814</td>
<td align="center">23.7±3.44</td>
<td align="center">24.7±3.50</td>
<td align="center">23.6±3.42</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Systolic blood pressure (mmHg)</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">121.2±13.8</td>
<td align="center" style="background-color:#F2F2F2">123.6±14.0</td>
<td align="center" style="background-color:#F2F2F2">121.0±13.7</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>Diastolic blood pressure (mmHg)</bold></td>
<td align="center">4810</td>
<td align="center">76.9±10.1</td>
<td align="center">79.7±9.74</td>
<td align="center">76.6±10.1</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Blood urea nitrogen (mg/dL)</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">14.1±3.62</td>
<td align="center" style="background-color:#F2F2F2">16.6±5.61</td>
<td align="center" style="background-color:#F2F2F2">13.9±3.26</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>Creatinine (mg/dL)</bold></td>
<td align="center">4814</td>
<td align="center">0.8 (0.8–0.9)</td>
<td align="center">1.1 (1.1–1.2)</td>
<td align="center">0.8 (0.8–0.9)</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>eGFR (ml/min/1.73m<sup>2</sup>)</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">77.6±14.4</td>
<td align="center" style="background-color:#F2F2F2">52.8±7.84</td>
<td align="center" style="background-color:#F2F2F2">80.0±12.5</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>Uric acid (mg/dL)</bold></td>
<td align="center">4814</td>
<td align="center">6.08±1.28</td>
<td align="center">6.89±1.36</td>
<td align="center">6.01±1.25</td>
<td align="char" char=".">0.039<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Total cholesterol (mg/dL)</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">203.8±33.7</td>
<td align="center" style="background-color:#F2F2F2">207.0±35.1</td>
<td align="center" style="background-color:#F2F2F2">203.5±33.5</td>
<td align="char" char="." style="background-color:#F2F2F2">0.096</td>
</tr>
<tr>
<td align="left"><bold>Triglyceride (mg/dL)</bold></td>
<td align="center">4813</td>
<td align="center">102 (70–153)</td>
<td align="center">111 (79–167.5)</td>
<td align="center">101 (70–150)</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>High density lipoprotein (mg/dL)</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">58.2±15.1</td>
<td align="center" style="background-color:#F2F2F2">57.0±16.1</td>
<td align="center" style="background-color:#F2F2F2">58.3±15.0</td>
<td align="char" char="." style="background-color:#F2F2F2">0.10</td>
</tr>
<tr>
<td align="left"><bold>Low density lipoprotein (mg/dL)</bold></td>
<td align="center">4814</td>
<td align="center">123.2±30.4</td>
<td align="center">126.5±31.1</td>
<td align="center">122.9±30.3</td>
<td align="char" char=".">0.018<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Fasting blood glucose</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">92 (87–99)</td>
<td align="center" style="background-color:#F2F2F2">94 (88–101)</td>
<td align="center" style="background-color:#F2F2F2">92 (87–99)</td>
<td align="char" char="." style="background-color:#F2F2F2">0.0032<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>HbA<sub>1</sub>c</bold></td>
<td align="center">4814</td>
<td align="center">5.32±0.64</td>
<td align="center">5.34±0.59</td>
<td align="center">5.32±0.64</td>
<td align="char" char=".">0.55</td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Urinary protein positivity on dipstick</bold></td>
<td align="center" style="background-color:#F2F2F2">4814</td>
<td align="center" style="background-color:#F2F2F2">263, 5.46%</td>
<td align="center" style="background-color:#F2F2F2">59, 13.66%</td>
<td align="center" style="background-color:#F2F2F2">204, 4.66%</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>Lifestyle</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold> Exercise habits</bold></td>
<td align="center" style="background-color:#F2F2F2">4805</td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>  None</bold></td>
<td align="center"/>
<td align="center">1562, 32.51%</td>
<td align="center">100, 23.26%</td>
<td align="center">1462, 33.42%</td>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>  &lt;6 days per week</bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2">2425, 50.47%</td>
<td align="center" style="background-color:#F2F2F2">248, 57.67%</td>
<td align="center" style="background-color:#F2F2F2">2177, 49.76%</td>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="left"><bold>  Every day</bold></td>
<td align="center"/>
<td align="center">818, 17.02%</td>
<td align="center">82, 19.07%</td>
<td align="center">736, 16.82%</td>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold> Drinking habits</bold></td>
<td align="center" style="background-color:#F2F2F2">4806</td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left"><bold>  None</bold></td>
<td align="center"/>
<td align="center">1130, 23.51%</td>
<td align="center">113, 26.28%</td>
<td align="center">1017, 23.24%</td>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>  &lt;2 days per week</bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2">1168, 24.3%</td>
<td align="center" style="background-color:#F2F2F2">123, 28.6%</td>
<td align="center" style="background-color:#F2F2F2">1045, 23.88%</td>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="left"><bold>  3–6 days per week</bold></td>
<td align="center"/>
<td align="center">780, 16.23%</td>
<td align="center">77, 17.91%</td>
<td align="center">703, 16.06%</td>
<td align="center"/>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>  Every day</bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2">1728, 35.96%</td>
<td align="center" style="background-color:#F2F2F2">117, 27.21%</td>
<td align="center" style="background-color:#F2F2F2">1611, 36.81%</td>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="left"><bold> Smoking</bold></td>
<td align="center">4810</td>
<td align="center">1783, 37.07%</td>
<td align="center">87, 20.19%</td>
<td align="center">1696, 38.73%</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold> Stress</bold></td>
<td align="center" style="background-color:#F2F2F2">4806</td>
<td align="center" style="background-color:#F2F2F2">3921, 81.59%</td>
<td align="center" style="background-color:#F2F2F2">339, 78.84%</td>
<td align="center" style="background-color:#F2F2F2">3582, 81.86%</td>
<td align="char" char="." style="background-color:#F2F2F2">0.12</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>CKD, chronic kidney disease. Continuous data are presented as mean ± SD or medians (1st quartile, 3rd quartile) and categorical data as n values (%).</p></fn>
<fn id="t001fn002"><p>*<italic>P</italic> value &lt; 0.05.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Linear regression analysis between SNPs and eGFR</title>
<p><xref ref-type="supplementary-material" rid="pone.0185476.s002">S2 Table</xref> showed the univariate and multivariate regression analyses between eGFR and SNPs. In the multivariate linear regression adjusted for age, BMI, SBP, and FBG, we found eight candidate SNPs with <italic>P</italic> value &lt; 0.05: <italic>CX3CR1</italic> rs3732379, <italic>SHROOM3</italic> rs17319721, <italic>MTP</italic> rs1800591, <italic>PIP5K1B</italic> rs4744712, <italic>APOA5</italic> rs662799, <italic>BRAP</italic> rs3782886, <italic>SPATA5L1</italic> rs2467853, and <italic>MCP1</italic> rs1024611. Among these SNPs, <italic>BRAP</italic> rs3782886 and <italic>SPATA5L1</italic> rs2467853 were significantly associated with eGFR (FDR &lt; 0.05) (<xref ref-type="table" rid="pone.0185476.t002">Table 2</xref>).</p>
<table-wrap id="pone.0185476.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0185476.t002</object-id>
<label>Table 2</label> <caption><title>Multivariate linear regression analysis of the association between eGFR and SNPs.</title></caption>
<alternatives>
<graphic id="pone.0185476.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify">rs#</th>
<th align="center">Near gene</th>
<th align="center">Major/minor allele</th>
<th align="center">Risk allele<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref></th>
<th align="center">Coefficient<xref ref-type="table-fn" rid="t002fn003"><sup>b</sup></xref></th>
<th align="center">95%CI</th>
<th align="center"><italic>P</italic> value</th>
<th align="center">FDR</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" style="background-color:#F2F2F2"><bold>rs3732379</bold></td>
<td align="center" style="background-color:#F2F2F2"><italic>CX3CR1</italic></td>
<td align="center" style="background-color:#F2F2F2">C/T</td>
<td align="center" style="background-color:#F2F2F2">C</td>
<td align="char" char="." style="background-color:#F2F2F2">1.25</td>
<td align="center" style="background-color:#F2F2F2">(0.004, 2.50)</td>
<td align="char" char="." style="background-color:#F2F2F2">0.049</td>
<td align="char" char="." style="background-color:#F2F2F2">0.36</td>
</tr>
<tr>
<td align="justify"><bold>rs17319721</bold></td>
<td align="center"><italic>SHROOM3</italic></td>
<td align="center">G/A</td>
<td align="center">A</td>
<td align="char" char=".">-1.16</td>
<td align="center">(-2.15, -0.16)</td>
<td align="char" char=".">0.023</td>
<td align="char" char=".">0.24</td>
</tr>
<tr>
<td align="justify" style="background-color:#F2F2F2"><bold>rs1800591</bold></td>
<td align="center" style="background-color:#F2F2F2"><italic>MTP</italic></td>
<td align="center" style="background-color:#F2F2F2">G/T</td>
<td align="center" style="background-color:#F2F2F2">G</td>
<td align="char" char="." style="background-color:#F2F2F2">0.99</td>
<td align="center" style="background-color:#F2F2F2">(0.26, 1.72)</td>
<td align="char" char="." style="background-color:#F2F2F2">0.0077</td>
<td align="char" char="." style="background-color:#F2F2F2">0.13</td>
</tr>
<tr>
<td align="justify"><bold>rs4744712</bold></td>
<td align="center"><italic>PIP5K1B</italic></td>
<td align="center">C/A</td>
<td align="center">A</td>
<td align="char" char=".">-0.75</td>
<td align="center">(-1.31, -0.19)</td>
<td align="char" char=".">0.0088</td>
<td align="char" char=".">0.13</td>
</tr>
<tr>
<td align="justify" style="background-color:#F2F2F2"><bold>rs662799</bold></td>
<td align="center" style="background-color:#F2F2F2"><italic>APOA5</italic></td>
<td align="center" style="background-color:#F2F2F2">A/G</td>
<td align="center" style="background-color:#F2F2F2">G</td>
<td align="char" char="." style="background-color:#F2F2F2">-0.61</td>
<td align="center" style="background-color:#F2F2F2">(-1.18, -0.046)</td>
<td align="char" char="." style="background-color:#F2F2F2">0.034</td>
<td align="char" char="." style="background-color:#F2F2F2">0.29</td>
</tr>
<tr>
<td align="justify"><bold>rs3782886</bold></td>
<td align="center"><italic>BRAP</italic></td>
<td align="center">A/G</td>
<td align="center">G</td>
<td align="char" char=".">-1.63</td>
<td align="center">(-2.25, -1.02)</td>
<td align="char" char=".">&lt;0.0001</td>
<td align="char" char=".">&lt;0.0001<xref ref-type="table-fn" rid="t002fn004"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="justify" style="background-color:#F2F2F2"><bold>rs2467853</bold></td>
<td align="center" style="background-color:#F2F2F2"><italic>SPATA5L1</italic></td>
<td align="center" style="background-color:#F2F2F2">G/T</td>
<td align="center" style="background-color:#F2F2F2">G</td>
<td align="char" char="." style="background-color:#F2F2F2">2.07</td>
<td align="center" style="background-color:#F2F2F2">(0.89, 3.24)</td>
<td align="char" char="." style="background-color:#F2F2F2">0.0006</td>
<td align="char" char="." style="background-color:#F2F2F2">0.018 <xref ref-type="table-fn" rid="t002fn004"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="justify"><bold>rs1024611</bold></td>
<td align="center"><italic>MCP1</italic></td>
<td align="center">C/T</td>
<td align="center">T</td>
<td align="char" char=".">-0.65</td>
<td align="center">(-1.22, -0.084)</td>
<td align="char" char=".">0.025</td>
<td align="char" char=".">0.24</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>rs#, rs number; CI, confidence interval; FDR, false discovery rate</p></fn>
<fn id="t002fn002"><p><sup>a</sup> The allele that decreased eGFR was defined as risk allele.</p></fn>
<fn id="t002fn003"><p><sup>b</sup> Coefficient represents the value of eGFR increase as the number of minor allele increased by 1</p></fn>
<fn id="t002fn004"><p><sup>c</sup> FDR &lt; 0.05.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec016">
<title>Effects of genetic risk score on CKD</title>
<p>Linear regression analysis revealed eight candidate SNPs associated with kidney function. Subsequently, we calculated GRS by adding the total number of risk alleles. The mean value of GRS was 8.3 (± 1.6), and the maximum and minimum values were 14 and 3, respectively.</p>
<p>Multiple models analyzing the association between GRS and CKD are shown in <xref ref-type="table" rid="pone.0185476.t003">Table 3</xref>. After adjusting for relevant clinical factors, GRS was shown to be an independent factor associated with CKD. C-statistics showed marginally significant improvement by using GRS (<italic>P</italic> = 0.061), whereas IDI and NRI showed a significant improvement (P = 0.0028 and &lt; 0.0001, respectively).</p>
<table-wrap id="pone.0185476.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0185476.t003</object-id>
<label>Table 3</label> <caption><title>Univariate and multivariate logistic regression analysis of SNP Score and CKD.</title></caption>
<alternatives>
<graphic id="pone.0185476.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center">OR</th>
<th align="center">95% CI</th>
<th align="center"><italic>P</italic> value</th>
<th align="center">C-statistics with GRS</th>
<th align="center">C-statistics without GRS</th>
<th align="center"><italic>P</italic> value</th>
<th align="center">IDI</th>
<th align="center"><italic>P</italic> value</th>
<th align="center">NRI</th>
<th align="center"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" style="background-color:#F2F2F2"><bold>Univariate</bold></td>
<td align="char" char="." style="background-color:#F2F2F2">1.16</td>
<td align="center" style="background-color:#F2F2F2">[1.08–1.23]</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char="." style="background-color:#F2F2F2">0.562</td>
<td align="center" style="background-color:#F2F2F2">-</td>
<td align="center" style="background-color:#F2F2F2">-</td>
<td align="center" style="background-color:#F2F2F2">-</td>
<td align="center" style="background-color:#F2F2F2">-</td>
<td align="center" style="background-color:#F2F2F2">-</td>
<td align="center" style="background-color:#F2F2F2">-</td>
</tr>
<tr>
<td align="justify"><bold>Model 1</bold></td>
<td align="char" char=".">1.17</td>
<td align="center">[1.10–1.25]</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char=".">0.686</td>
<td align="char" char=".">0.674</td>
<td align="char" char=".">0.0090<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char=".">0.0049</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char=".">0.203</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
</tr>
<tr>
<td align="justify" style="background-color:#F2F2F2"><bold>Model 2</bold></td>
<td align="char" char="." style="background-color:#F2F2F2">1.16</td>
<td align="center" style="background-color:#F2F2F2">[1.08–1.24]</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char="." style="background-color:#F2F2F2">0.713</td>
<td align="char" char="." style="background-color:#F2F2F2">0.706</td>
<td align="char" char="." style="background-color:#F2F2F2">0.062</td>
<td align="char" char="." style="background-color:#F2F2F2">0.0046</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char="." style="background-color:#F2F2F2">0.200</td>
<td align="char" char="." style="background-color:#F2F2F2">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
</tr>
<tr>
<td align="justify"><bold>Model 3</bold></td>
<td align="char" char=".">1.15</td>
<td align="center">[1.08–1.23]</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char=".">0.716</td>
<td align="char" char=".">0.709</td>
<td align="char" char=".">0.061</td>
<td align="char" char=".">0.0057</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
<td align="char" char=".">0.212</td>
<td align="char" char=".">&lt;0.001<xref ref-type="table-fn" rid="t003fn002">*</xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>CI, confidence interval; GRS, genetic risk score; IDI, integrated discrimination improvement; NRI, net reclassification improvement. Model 1: adjusted for age, body mass index, systolic blood pressure, and fasting blood glucose. Model 2: model 1 + exercise habit, drinking habit, smoking, and stress. Model 3: model 2 + LDL cholesterol and fasting blood glucose, uric acid, and urinary protein through positive urine dipstick</p></fn>
<fn id="t003fn002"><p>* <italic>P</italic> &lt; 0.05</p></fn>
</table-wrap-foot>
</table-wrap>
<p>We constructed wGRS based on the logistic regression analysis shown in <xref ref-type="supplementary-material" rid="pone.0185476.s003">S3 Table</xref>. We multiplied the coefficient from the logistic regression analysis by 20 then added 25. The mean value of wGRS was 29.1 (± 5.7), and the maximum and minimum values were 46 and 1, respectively.</p>
<p>Multiple models analyzing the association between wGRS and CKD are shown in <xref ref-type="supplementary-material" rid="pone.0185476.s004">S4 Table</xref>. We also showed that wGRS is an independent factor associated with CKD. C-statistics, IDI, and NRI showed statistically significant improvement by using wGRS (<italic>P</italic> = 0.040, &lt; 0.001, &lt; 0.001, respectively).</p>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<p>In this study, we showed a significant association between kidney function and genetic polymorphism, specifically <italic>BRAP</italic> rs3782886 and <italic>SPATA5L1</italic> rs2467853, after adjustment for clinical factors including lifestyle information. Moreover, we developed a GRS for chronic kidney disease, and used it in male workers who regularly undergo health checkups.</p>
<p>Several GWAS and candidate gene studies revealed the SNPs associated with kidney disease or kidney function [<xref ref-type="bibr" rid="pone.0185476.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0185476.ref017">17</xref>]. Our study was unique as annual health examination data, particularly among middle-aged men, in a manufacturing company were used and a genetic risk score was developed. We developed a GRS combining the risk alleles in eight SNPs associated with kidney function, and examined its utility.</p>
<p><italic>BRAP</italic> rs3782886 and <italic>ALDH2</italic> rs671 have strong linkage disequilibrium according to the HapMap database [<xref ref-type="bibr" rid="pone.0185476.ref027">27</xref>]. Meta-analysis of GWAS in East Asian populations showed associations between the SNP <italic>ALDH2</italic> rs671 and obesity and various cardiovascular risk factors and coronary artery disease (CAD) [<xref ref-type="bibr" rid="pone.0185476.ref028">28</xref>]. The minor allele of <italic>ALDH2</italic> rs671 was associated with CAD, high LDL, and low HDL, while the major allele was associated with high blood pressure, and high FBG. Another meta-analysis of GWAS in East Asian populations showed associations between the SNP <italic>ALDH2</italic> rs671 and kidney function [<xref ref-type="bibr" rid="pone.0185476.ref017">17</xref>] and revealed that the minor allele was associated with worse kidney function. In our study, the minor allele of <italic>BRAP</italic> rs3782886 was associated with lower kidney function, which is consistent with a previous study. A prospective study is necessary to investigate how <italic>BRAP</italic> rs3782886 affects the development of CVD and ESRD.</p>
<p>Moreover, similar to a previous study, our study also showed a significant association between <italic>SPATA5L1</italic> rs2467853 and kidney function [<xref ref-type="bibr" rid="pone.0185476.ref029">29</xref>]. <italic>SPATA5L1</italic> rs2467853 is an intronic SNP associated with glomerular filtration rate, which was estimated using serum creatinine, among European-descent participants from multiple cohorts; however, the biological significance remains unclear. Furthermore, a previous study showed that the <italic>CX3CR1</italic> rs3732379 SNP CC genotype is associated with increased risk of delayed graft function among patients who received renal transplantation [<xref ref-type="bibr" rid="pone.0185476.ref030">30</xref>]. In a study that first reported on the kidney function of a general population, CX3CR1 rs3732379 SNP was associated with atherosclerosis of the coronary artery [<xref ref-type="bibr" rid="pone.0185476.ref031">31</xref>], <italic>SHROOM3</italic> rs17319721 and <italic>PIP5K1B</italic> rs4744712 were associated with kidney disease [<xref ref-type="bibr" rid="pone.0185476.ref029">29</xref>,<xref ref-type="bibr" rid="pone.0185476.ref032">32</xref>]. The minor allele of <italic>MTP</italic> rs1800591 was shown to be associated with hypertension in a Mexican population [<xref ref-type="bibr" rid="pone.0185476.ref033">33</xref>] and, in another study, with lower cholesterol level but ischemic heart disease [<xref ref-type="bibr" rid="pone.0185476.ref034">34</xref>]; in the present study, the major allele of <italic>MTP</italic> rs1800591 was associated with worse kidney function. No related study on kidney function exists; thus, further studies are needed. Moreover, <italic>APOA5</italic> rs662799 was associated with CKD in the Japanese general population [<xref ref-type="bibr" rid="pone.0185476.ref035">35</xref>]. <italic>MCP1</italic> rs1024611 was associated with carotid artery plaque, ischemic stroke (IS), and ischemic heart disease (IHD) [<xref ref-type="bibr" rid="pone.0185476.ref036">36</xref>,<xref ref-type="bibr" rid="pone.0185476.ref037">37</xref>]. The rs1024611C(G) allele is associated with increased serum MCP-1 levels and enhanced leukocyte recruitment to the tissues among Caucasians, which in turn could lead to atherosclerosis [<xref ref-type="bibr" rid="pone.0185476.ref038">38</xref>]. One meta-analysis showed that C(G) allele is a risk allele for IHD and IS [<xref ref-type="bibr" rid="pone.0185476.ref036">36</xref>], while some previous studies showed that T(A) is a risk allele for the development of diabetic nephropathy among the Asian population [<xref ref-type="bibr" rid="pone.0185476.ref039">39</xref>,<xref ref-type="bibr" rid="pone.0185476.ref040">40</xref>]. Whether <italic>MCP1</italic> rs1024611 causes arteriosclerosis via MCP-1 level change among Asians remains unclear; hence, further studies are needed.</p>
<p>Limitations of this study include the possibility of a sampling bias. Participation in the study was based on the willingness of individuals; consequently, the number of study participants was limited. New findings have been accumulated since we started this research; thus, the selection of SNPs could also be a limitation. In addition, two further limitations regarding model construction in this study were noted: First, we used the same sample to get the weight for the weighted genetic score analysis. Thus, the results for weighted models could have been inflated. We could not have a different cohort to validate the effect of GRS. Hence, further studies should perform such an analysis with a different sample. Second, we also considered wGRS to reflect the difference in the effect of each variant. However, a comparison between the simple counting method (using GRS) and the scoring system (using wGRS) showed that AUCs were similar. Therefore, the simple counting of risk alleles could be feasible and useful. Lastly, the cross-sectional nature of this study limits our ability to estimate the longitudinal effects. Long-term observation of our study’s cohort will help in understanding and identifying individuals at a high risk of developing CKD and CVD.</p>
<p>In conclusion, a significant association between kidney function and genetic polymorphism, specifically <italic>BRAP</italic> rs3782886 and <italic>SPATA5L1</italic> rs2467853, exists. The GRS for chronic kidney disease that we developed was found to be useful in risk evaluation among middle-aged Japanese men. Nevertheless, validating the utility of GRS among other populations is necessary. In addition, a prospective observation of high-risk populations is warranted to confirm such association.</p>
</sec>
<sec id="sec018">
<title>Supporting information</title>
<supplementary-material id="pone.0185476.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Characteristics of genotyped SNPs.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0185476.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.s002" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Crude and adjusted logistic regression analysis of association between eGFR and SNPs.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0185476.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.s003" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Result of logistic regression analysis performed for weighting.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0185476.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.s004" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Univariate and multivariate logistic regression analyses of weighted SNP score and CKD.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0185476.s005" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0185476.s005" xlink:type="simple">
<label>S1 Dataset</label>
<caption>
<title>Clinical data of 4814 study participants.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank Toyota Motor Co., Ltd. for providing annual health examination data and for the support in developing medicine and promoting the health of their employees; Editage for providing editorial and publication support; and Ms. Hiraoka for SNP typing. Finally, we would also like to express our gratitude to Dr. Seiichi Matsuo, a former professor of the Department of Nephrology in Nagoya University Graduate School and currently the president of Nagoya University, for supporting the fundraising and constructing the research system.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0185476.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Keith</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Nichols</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Gullion</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>DH</given-names></name>. <article-title>Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization</article-title>. <source>Arch Intern Med</source>. <year>2004</year>;<volume>164</volume>: <fpage>659</fpage>–<lpage>663</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archinte.164.6.659" xlink:type="simple">10.1001/archinte.164.6.659</ext-link></comment> <object-id pub-id-type="pmid">15037495</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Go</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Chertow</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Fan</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>McCulloch</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>C</given-names></name>. <article-title>Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization</article-title>. <source>N Engl J Med</source>. <year>2004</year>;<volume>351</volume>: <fpage>1296</fpage>–<lpage>1305</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa041031" xlink:type="simple">10.1056/NEJMoa041031</ext-link></comment> <object-id pub-id-type="pmid">15385656</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muntner</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hamm</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Loria</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Whelton</surname> <given-names>PK</given-names></name>. <article-title>Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States</article-title>. <source>J Am Soc Nephrol</source>. <year>2002</year>;<volume>13</volume>: <fpage>745</fpage>–<lpage>753</lpage>. <object-id pub-id-type="pmid">11856780</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manjunath</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Tighiouart</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ibrahim</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>MacLeod</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Salem</surname> <given-names>DN</given-names></name>, <name name-style="western"><surname>Griffith</surname> <given-names>JL</given-names></name>, <etal>et al</etal>. <article-title>Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community</article-title>. <source>J Am Coll Cardiol</source>. <year>2003</year>;<volume>41</volume>: <fpage>47</fpage>–<lpage>55</lpage>. <object-id pub-id-type="pmid">12570944</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imai</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Horio</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Iseki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yamagata</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hara</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Prevalence of chronic kidney disease in the Japanese general population</article-title>. <source>Clin Exp Nephrol</source>. <year>2009</year>;<volume>13</volume>: <fpage>621</fpage>–<lpage>630</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10157-009-0199-x" xlink:type="simple">10.1007/s10157-009-0199-x</ext-link></comment> <object-id pub-id-type="pmid">19513802</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamagata</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ishida</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sairenchi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ohba</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shiigai</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study</article-title>. <source>Kidney Int</source>. <year>2007</year>;<volume>71</volume>: <fpage>159</fpage>–<lpage>166</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.ki.5002017" xlink:type="simple">10.1038/sj.ki.5002017</ext-link></comment> <object-id pub-id-type="pmid">17136030</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iseki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tozawa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ikemiya</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kinjo</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Iseki</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Takishita</surname> <given-names>S</given-names></name>. <article-title>Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort</article-title>. <source>Clin Exp Nephrol</source>. <year>2005</year>;<volume>9</volume>: <fpage>46</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10157-004-0332-9" xlink:type="simple">10.1007/s10157-004-0332-9</ext-link></comment> <object-id pub-id-type="pmid">15830273</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hashimoto</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Okada</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Senmaru</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hamaguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Asano</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Metabolically healthy obesity and risk of incident CKD</article-title>. <source>Clin J Am Soc Nephrol</source>. <year>2015</year>;<volume>10</volume>: <fpage>578</fpage>–<lpage>583</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2215/CJN.08980914" xlink:type="simple">10.2215/CJN.08980914</ext-link></comment> <object-id pub-id-type="pmid">25635035</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tozawa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Iseki</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tokashiki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Chinen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kohagura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kinjo</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults</article-title>. <source>Hypertens Res</source>. <year>2007</year>;<volume>30</volume>: <fpage>937</fpage>–<lpage>943</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1291/hypres.30.937" xlink:type="simple">10.1291/hypres.30.937</ext-link></comment> <object-id pub-id-type="pmid">18049025</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tanaka</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Shiohira</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Uezu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Higa</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Iseki</surname> <given-names>K</given-names></name>. <article-title>Metabolic syndrome and chronic kidney disease in Okinawa, Japan</article-title>. <source>Kidney Int</source>. <year>2006</year>;<volume>69</volume>: <fpage>369</fpage>–<lpage>374</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.ki.5000050" xlink:type="simple">10.1038/sj.ki.5000050</ext-link></comment> <object-id pub-id-type="pmid">16408128</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Muntner</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hamm</surname> <given-names>LL</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Batuman</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Fonseca</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>The metabolic syndrome and chronic kidney disease in U.S. adults</article-title>. <source>Ann Intern Med</source>. <year>2004</year>;<volume>140</volume>: <fpage>167</fpage>–<lpage>174</lpage>. <object-id pub-id-type="pmid">14757614</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoshida</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kato</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Fujimaki</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yokoi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Oguri</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Association of genetic variants with chronic kidney disease in Japanese individuals</article-title>. <source>Clin J Am Soc Nephrol</source>. <year>2009</year>;<volume>4</volume>: <fpage>883</fpage>–<lpage>890</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2215/CJN.04350808" xlink:type="simple">10.2215/CJN.04350808</ext-link></comment> <object-id pub-id-type="pmid">19406964</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Köttgen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pattaro</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Böger</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Fuchsberger</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Olden</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Glazer</surname> <given-names>NL</given-names></name>, <etal>et al</etal>. <article-title>New loci associated with kidney function and chronic kidney disease</article-title>. <source>Nat Genet</source>. <year>2010</year>;<volume>42</volume>: <fpage>376</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.568" xlink:type="simple">10.1038/ng.568</ext-link></comment> <object-id pub-id-type="pmid">20383146</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Böger</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Gorski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hoffmann</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>Association of eGFR-related loci identified by GWAS with incident CKD and ESRD</article-title>. <name name-style="western"><surname>Kim</surname> <given-names>SK</given-names></name><strike>, editor.</strike> <source>PLoS Genet</source>. <year>2011</year>;<volume>7</volume>: <fpage>e1002292</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1002292" xlink:type="simple">10.1371/journal.pgen.1002292</ext-link></comment> <object-id pub-id-type="pmid">21980298</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gorski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Garnaas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>McMahon</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Tayo</surname> <given-names>BO</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association study of kidney function decline in individuals of European descent</article-title>. <source>Kidney Int</source>. <year>2015</year>; <volume>87</volume>: <fpage>1017</fpage>–<lpage>1029</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ki.2014.361" xlink:type="simple">10.1038/ki.2014.361</ext-link></comment> <object-id pub-id-type="pmid">25493955</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hishida</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Morita</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Naito</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Okada</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wakai</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Matsuo</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese—a cross-sectional data from the J-MICC Study</article-title>. <source>Endocr J</source>. <year>2012</year>;<volume>59</volume>: <fpage>589</fpage>–<lpage>599</lpage>. <object-id pub-id-type="pmid">22517333</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okada</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sim</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Go</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J-Y</given-names></name>, <name name-style="western"><surname>Gu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Takeuchi</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations</article-title>. <source>Nat Genet</source>. <year>2012</year>;<volume>44</volume>: <fpage>904</fpage>–<lpage>909</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2352" xlink:type="simple">10.1038/ng.2352</ext-link></comment> <object-id pub-id-type="pmid">22797727</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakatochi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ushida</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yasuda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yoshida</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kawai</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kato</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Identification of an interaction between VWF rs7965413 and platelet count as a novel risk marker for metabolic syndrome: an extensive search of candidate polymorphisms in a case-control study</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>: <fpage>e0117591</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0117591" xlink:type="simple">10.1371/journal.pone.0117591</ext-link></comment> <object-id pub-id-type="pmid">25646961</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imaizumi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ando</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nakatochi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yasuda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Honda</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kuwatsuka</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Effect of dietary energy and polymorphisms in BRAP and GHRL on obesity and metabolic traits</article-title>. <source>Obes Res Clin Pract</source>. <year>2016</year>; <month>May</month>. pii: S1871-403X(16)30032-1. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.orcp.2016.05.004" xlink:type="simple">10.1016/j.orcp.2016.05.004</ext-link></comment> <object-id pub-id-type="pmid">27245511</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imaizumi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ando</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nakatochi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Maruyama</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yasuda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Honda</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers</article-title>. <source>Clin Exp Nephrol</source>. Epub 2016 Aug 1.</mixed-citation></ref>
<ref id="pone.0185476.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Imai</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Horio</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yasuda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tomita</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nitta</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Revised equations for estimated GFR from serum creatinine in Japan</article-title>. <source>Am J Kidney Dis</source>. <year>2009</year>;<volume>53</volume>: <fpage>982</fpage>–<lpage>992</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.ajkd.2008.12.034" xlink:type="simple">10.1053/j.ajkd.2008.12.034</ext-link></comment> <object-id pub-id-type="pmid">19339088</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nishida</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Tanabe</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Takasu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Suyama</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tokunaga</surname> <given-names>K</given-names></name>. <article-title>Further development of multiplex single nucleotide polymorphism typing method, the DigiTag2 assay</article-title>. <source>Anal Biochem</source>. <year>2007</year>;<volume>364</volume>: <fpage>78</fpage>–<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ab.2007.02.005" xlink:type="simple">10.1016/j.ab.2007.02.005</ext-link></comment> <object-id pub-id-type="pmid">17359929</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wakasugi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kazama</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kawamura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Narita</surname> <given-names>I</given-names></name>. <article-title>A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study</article-title>. <source>Hypertens Res</source>. <year>2013</year>;<volume>36</volume>: <fpage>328</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/hr.2012.186" xlink:type="simple">10.1038/hr.2012.186</ext-link></comment> <object-id pub-id-type="pmid">23171953</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bruce</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Griffith</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Thorpe</surname> <given-names>RJ</given-names></name>. <article-title>Stress and the kidney</article-title>. <source>Adv Chronic Kidney Dis</source>. <year>2015</year>;<volume>22</volume>: <fpage>46</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.ackd.2014.06.008" xlink:type="simple">10.1053/j.ackd.2014.06.008</ext-link></comment> <object-id pub-id-type="pmid">25573512</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeLong</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>DeLong</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Clarke-Pearson</surname> <given-names>DL</given-names></name>. <article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</article-title>. <source>Biometrics</source>. <year>1988</year>;<volume>44</volume>: <fpage>837</fpage>–<lpage>845</lpage>. <object-id pub-id-type="pmid">3203132</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pencina</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>D’Agostino</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>D’Agostino</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Vasan</surname> <given-names>RS</given-names></name>. <article-title>Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond</article-title>. <source>Stat Med</source>. <year>2008</year>;<volume>27</volume>: <fpage>157</fpage>–<lpage>172</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/sim.2929" xlink:type="simple">10.1002/sim.2929</ext-link></comment> <object-id pub-id-type="pmid">17569110</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref027"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">The International HapMap Project. <ext-link ext-link-type="uri" xlink:href="http://hapmap.ncbi.nlm.nih.gov/" xlink:type="simple">http://hapmap.ncbi.nlm.nih.gov/</ext-link></mixed-citation></ref>
<ref id="pone.0185476.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kato</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Takeuchi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Tabara</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kelly</surname> <given-names>TN</given-names></name>, <name name-style="western"><surname>Go</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Sim</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians</article-title>. <source>Nat Genet</source>. <year>2011</year>;<volume>43</volume>: <fpage>531</fpage>–<lpage>538</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.834" xlink:type="simple">10.1038/ng.834</ext-link></comment> <object-id pub-id-type="pmid">21572416</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Köttgen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Glazer</surname> <given-names>NL</given-names></name>, <name name-style="western"><surname>Dehghan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>S-J</given-names></name>, <name name-style="western"><surname>Katz</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Multiple loci associated with indices of renal function and chronic kidney disease</article-title>. <source>Nat Genet</source>. <year>2009</year>;<volume>41</volume>: <fpage>712</fpage>–<lpage>717</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.377" xlink:type="simple">10.1038/ng.377</ext-link></comment> <object-id pub-id-type="pmid">19430482</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dabrowska-Zamojcin</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Dziedziejko</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Safranow</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kurzawski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Domanski</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pawlik</surname> <given-names>A</given-names></name>. <article-title>Association between the CX3CR1 gene V249I polymorphism and delayed kidney allograft function</article-title>. <source>Transpl Immunol</source>. <year>2015</year>;<volume>32</volume>: <fpage>172</fpage>–<lpage>174</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.trim.2015.04.002" xlink:type="simple">10.1016/j.trim.2015.04.002</ext-link></comment> <object-id pub-id-type="pmid">25898802</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McDermott</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Halcox</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Schenke</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Waclawiw</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Merrell</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Epstein</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis</article-title>. <source>Circ Res</source>. <year>2001</year>;<volume>89</volume>: <fpage>401</fpage>–<lpage>407</lpage>. <object-id pub-id-type="pmid">11532900</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Böger</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Gorski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hoffmann</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>Association of eGFR-related loci identified by GWAS with incident CKD and ESRD</article-title>. <source>PLoS Genet</source>. <year>2011</year>;<volume>7</volume>: <fpage>3</fpage>–<lpage>10</lpage>.</mixed-citation></ref>
<ref id="pone.0185476.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ríos-González</surname> <given-names>BE</given-names></name>, <name name-style="western"><surname>Ibarra-Cortés</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ramírez-López</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sánchez-Corona</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Magaña-Torres</surname> <given-names>MT</given-names></name>. <article-title>Association of polymorphisms of genes involved in lipid metabolism with blood pressure and lipid values in Mexican hypertensive individuals</article-title>. <source>Dis Markers</source>. <year>2014</year>;<volume>2014</volume>: <fpage>150358</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2014/150358" xlink:type="simple">10.1155/2014/150358</ext-link></comment> <object-id pub-id-type="pmid">25587205</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ledmyr</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>McMahon</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Ehrenborg</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Neville</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lithell</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease</article-title>. <source>Circulation</source>. <year>2004</year>;<volume>109</volume>: <fpage>2279</fpage>–<lpage>2284</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.0000130070.96758.7b" xlink:type="simple">10.1161/01.CIR.0000130070.96758.7b</ext-link></comment> <object-id pub-id-type="pmid">15136504</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hishida</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wakai</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Naito</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Suma</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sasakabe</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hamajima</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese—cross-sectional data from the J-MICC study</article-title>. <source>Lipids Health Dis</source>. <year>2014</year>;<volume>13</volume>: <fpage>162</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1476-511X-13-162" xlink:type="simple">10.1186/1476-511X-13-162</ext-link></comment> <object-id pub-id-type="pmid">25311932</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cai</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Weng</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>Z</given-names></name>. <article-title>The associations between the MCP-1 −2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals</article-title>. <source>Mol Biol Rep</source>. <year>2015</year>;<volume>42</volume>: <fpage>997</fpage>–<lpage>1012</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11033-014-3836-8" xlink:type="simple">10.1007/s11033-014-3836-8</ext-link></comment> <object-id pub-id-type="pmid">25413568</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brenner</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Labreuche</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Touboul</surname> <given-names>P-J</given-names></name>, <name name-style="western"><surname>Schmidt-Petersen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Poirier</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Perret</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients</article-title>. <source>Stroke</source>. <year>2006</year>;<volume>37</volume>: <fpage>1691</fpage>–<lpage>1696</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.STR.0000226565.76113.6c" xlink:type="simple">10.1161/01.STR.0000226565.76113.6c</ext-link></comment> <object-id pub-id-type="pmid">16741188</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pham</surname> <given-names>MHT</given-names></name>, <name name-style="western"><surname>Bonello</surname> <given-names>GB</given-names></name>, <name name-style="western"><surname>Castiblanco</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Le</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sigala</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>: <fpage>e49498</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0049498" xlink:type="simple">10.1371/journal.pone.0049498</ext-link></comment> <object-id pub-id-type="pmid">23166687</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mao</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>S</given-names></name>. <article-title>Monocyte chemoattractant protein-1 -2518G/A gene polymorphism and the risk of nephropathy in type 2 diabetes mellitus among Asians: a meta-analysis</article-title>. <source>Ren Fail</source>. <year>2014</year>;<volume>36</volume>: <fpage>139</fpage>–<lpage>144</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/0886022X.2013.832690" xlink:type="simple">10.3109/0886022X.2013.832690</ext-link></comment> <object-id pub-id-type="pmid">24059294</object-id></mixed-citation></ref>
<ref id="pone.0185476.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Su</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H-Y</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>M-F</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>Z-P</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>T-B</given-names></name>. <article-title>Association of monocyte chemoattractant protein-1 2518G/A gene polymorphism with diabetic nephropathy risk</article-title>. <source>J Recept Signal Transduct Res</source>. <year>2015</year>;<volume>35</volume>: <fpage>94</fpage>–<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/10799893.2014.936458" xlink:type="simple">10.3109/10799893.2014.936458</ext-link></comment> <object-id pub-id-type="pmid">25051493</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>